Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
LUT University Position ID: LUT University -PME [#29964] Position Title: Position Location: Southern Finland, Finland [map ] Subject Area: Mechanical Engineering Appl Deadline: 2025/06/05 11:59PM
-
University of Eastern Finland Position ID: 3582 -PHD [#26562] Position Title: Position Type: Other Position Location: Joensuu, North Karelia 80101, Finland [map ] Subject Areas: Operator theory
-
Chinmey Dwibedi’s group at MIMS, Umeå, through the NORPOD program. Summary of the project The post-doctoral project aims to uncover genetic and adaptive mechanisms of the tumour associated microbiome in
-
% of annual working time). Requirements and eligibility criteria The Postdoctoral Researcher should have a PhD degree in computer science or bioinformatics (or related fields) with an emphasis on computational
-
NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research centers across the Nordics and the
-
Department of Computer Science of Faculty of Science invites applications for a DOCTORAL RESEARCHER IN ALGORITHMS AND COMPUTATIONAL BIOLOGY starting from September 2025, or as agreed. The Doctoral
-
-Cell Genomics through the NORPOD program NORPOD is a collaborative postdoctoral program of the Nordic EMBL Partnership for Molecular Medicine . The partnership is a network of four national research
-
group, established in 2018 at the University of Oslo, has recently expanded to the University of Helsinki. The group specializes in developing computational methods to understand the regulatory mechanisms
-
. The position is open to applicants with a PhD in computational biology, bioinformatics, biostatistics, cancer genomics, network science, or related fields. The appointment is a fulltime position and is made
-
experience in wet-lab and computational techniques. This position is intended for an MSc-level graduate planning to pursue a PhD degree. In this project, we aim to profile AML cancer cells treated with drug